Korean J Gastroenterol.
2000 Apr;35(4):517-521.
A Case of Pancreatic Ascites Controlled with Somatostatin Analogue (Octreotide)
Abstract
- Pancreatic ascites has the characteristics of highly proteinaceous, amylase-rich intraperitoneal fluid. It usually occurs as a result of rupture of a pseudocyst or disruption of main pancreatic duct during the course of acute or chronic pancreatitis. It can be managed by traditional conservative methods including fasting, total parenteral nutrition and ascites tapping or surgical interventions. Recently, several cases of treating pancreatic ascites with somatostatin analogue (octreotide) successfully have been reported. We experienced a patient with chronic pancreatitis and pancreatic ascites, who was successfully treated by somatostatin analogue (octreotide).
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Experience of Somatostatin Analogue in Various Pancreatic Diseases
- A Case of Mediastinal Pacreatic Pseudocyst Treated with Octreotide
- Treatment of Congenital Chylothorax in a Premature Infant using Octreotide
- The Role of Intracellular Ca2+ in Inhibiting Somatostatin-Induced Pancreatic Amylase Release
- A Case of Hepatic Carcinoid Tumor Regression with Octreotide
